← Back to Search

ECG Device

Atrial Fibrillation for Atrial Fibrillation

N/A
Recruiting
Led By Elaine WAN, MD
Research Sponsored by Withings
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4 months
Awards & highlights

Study Summary

This trialtests a heart monitor app to detect atrial fibrillation, a type of irregular heartbeat.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 4 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Co-
Secondary outcome measures
Clinical Equivalence of ECG waveforms
Evaluation of the classification into heart rate subgroups
Heart Rate equivalence

Trial Design

2Treatment groups
Experimental Treatment
Group I: Normal Sinus RhythmExperimental Treatment1 Intervention
Group II: Atrial FibrillationExperimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

WithingsLead Sponsor
19 Previous Clinical Trials
3,930 Total Patients Enrolled
7 Trials studying Atrial Fibrillation
1,941 Patients Enrolled for Atrial Fibrillation
SyntactxNETWORK
22 Previous Clinical Trials
1,146,736 Total Patients Enrolled
1 Trials studying Atrial Fibrillation
632 Patients Enrolled for Atrial Fibrillation
Elaine WAN, MDPrincipal InvestigatorColumbia University Irving Medical Center/ NewYork Presbyterian Hospital
1 Previous Clinical Trials
632 Total Patients Enrolled
1 Trials studying Atrial Fibrillation
632 Patients Enrolled for Atrial Fibrillation

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~237 spots leftby Mar 2025